Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria

Applied and Environmental Microbiology

Volumn 78, Issue 4, 2012, Pages 933-940

  Palaria, Amrita ^a,b   Johnson Kanda, Ivy ^a   O'Sullivan, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Kerry Ingredients and Flavours   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL LEVELS; BIFIDOBACTERIA; BIFIDOBACTERIUM; ENTEROBACTERIA; FECAL SAMPLES; FEEDING PERIOD; HUMAN INTESTINE; MICROBIAL GROUPS; PLACEBO GROUPS; PROBIOTICS; REAL-TIME PCR; TIME POINTS;

BACTERIA; POLYMERASE CHAIN REACTION; POLYSACCHARIDES;

DAIRY PRODUCTS;

INULIN; PLACEBO; YOGHURT;

BACTERIUM; INGESTION RATE; POLYMERASE CHAIN REACTION; REAL TIME; SAMPLING;

ARTICLE; BACTERIAL LOAD; BIFIDOBACTERIUM; CLINICAL TRIAL; CLOSTRIDIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; ENTEROBACTERIACEAE; FECES; GASTROINTESTINAL TRACT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

BACTERIAL LOAD; BIFIDOBACTERIUM; CLOSTRIDIUM; DIET; ENTEROBACTERIACEAE; FECES; GASTROINTESTINAL TRACT; HUMANS; INULIN; MICROBIAL VIABILITY; PLACEBOS; TIME FACTORS; YOGURT;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; CLOSTRIDIA; ENTEROBACTERIACEAE;

EID: 84857079653     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05848-11     Document Type: Article

References (43)

1. Alander M, et al. 2001. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int. Dairy J. 11:817-825.
2. Barnes EM, Ingram M. 1956. The effect of redox potential on the grown Clostridium welchii strain isolated from horse muscle. J. Appl. Bacteriol. 19:177-178.
3. Bartosch S, Woodmansey EJ, Paterson JCM, McMurdo MET, Macfarlane GT. 2005. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real time polymerase chain reaction and counting of viable bacteria. Clin. Infect. Dis. 40:28-37.
4. Cai YM, Matsumoto M, Benno Y. 2000. Bifidobacterium lactis Meile et al. 1997 is a subjective synonym of Bifidobacterium animalis (Mitsuoka 1969) Scardovi and Trovatelli 1974. Microbiol. Immunol. 44:815-820.
5. Fallani M, et al. 2006. Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16s rRNA targeted probes. J. Microbiol. Methods 67:150-161.
6. Fooks LJ, Gibson GR. 2002. Probiotics as modulators of the gut flora. Br. J. Nutr. 88:S39-S49.
7. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. 1998. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 42:239-244.
8. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. 2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17:259-275.
9. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125: 1401-1412.
10. Hébuterne X. 2003. Gut changes attributed to ageing: effects on intestinal microflora. Curr. Opin. Clin. Nutr. Metab. Care 6:49-54.
11. Hopkins MJ, MacFarlane GT. 2002. Changes in predominant bacterial populations in human feces with age and with Clostridium difficile infection. J. Med. Microbiol. 51:448-454.
12. Huijsdens XW, et al. 2002. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J. Clin. Microbiol. 40:4423-4427.
13. Islam A. 2005. Iron reversible inhibition by bifidobacteria and microbial diversity of the human intestine, p 40-42. M.S. thesis. University of Minnesota, St. Paul, MN.
14. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. 2000. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30:1604-1610.
15. Kaper JB, Karmali MA. 2008. The continuing evolution of a bacterial pathogen. Proc. Natl. Acad. Sci. U. S. A. 105:4535-4536.
16. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
17. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. 2002. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51-55.
18. Larsen CN, et al. 2006. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus paracasei subsp. paracasei CRL-341 in healthy young adults. Eur. J. Clin. Nutr. 60:1284-1293.
19. Lee JH, et al. 2008. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9:247-262.
20. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. 1994. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10:55-63.
21. Lyerly DM, Krivan HC, Wilkins TD. 1988. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1:1-18.
22. Malinen E, et al. 2002. PCR-ELISA. II: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation. Syst. Appl. Microbiol. 25:249-258.
23. Matto J, et al. 2006. Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yoghurt. Int. Dairy J. 16:1174-1180.
24. Meile L, et al. 1997. Bifidobacterium lactis. sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 20: 57-64.
25. Mitsuoka T. 1990. Bifidobacteria and their role in human health. J. Ind. Microbiol. 6:263-267.
26. Muñoa FJ, Pares R. 1988. Selective medium for isolation and enumeration of Bifidobacterium spp. Appl. Environ. Microbiol. 54:1715-1718.
27. Olsvik O, Wasteson Y, Lund A, Hornes E. 1991. Pathogenic Escherichia coli found in food. Int. J. Food Microbiol. 12:103-113.
28. O'Sullivan DJ. 2001. Screening of intestinal microflora for effective probiotic bacteria. J. Agric. Food Chem. 49:1751-1760.
29. O'Sullivan DJ. 2005. Primary sources of probiotic cultures, p 89-105. In Gopteke I, Juneja VK, Ahmedna M (ed), Probiotics in food safety and human health. CRC Press, Taylor & Francis Group, Boca Raton, FL.
30. Ouwehand AC, Kurvinen T, Rissanen P. 2004. Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. Int. J. Food Microbiol. 95:103-106.
31. Penders J, et al. 2005. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formulafed infants by real-time PCR. FEMS Microbiol. Lett. 243:141-147.
32. Playne MJ. 2002. The health benefits of probiotics. Food Aust. 54:71-74.
33. Rafter J, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85:488-496.
34. Requena T, et al. 2002. Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl. Environ. Microbiol. 68:2420-2427.
35. Roberfroid MB. 2005. Introducing inulin-type fructans. Br. J. Nutr. 93(Suppl. 1):S13-S25.
36. Rudi K, Moen B, Drømtorp SM, Holck AL. 2005. Use of ethidium monoazide and PCR in combination for quantification of viable and dead cells in complex samples. Appl. Environ. Microbiol. 71:1018-1024.
37. Saavedra JM, et al. 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049.
38. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimannp JM, Donnet-Hughes A. 1995. lmmunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78:491-497.
39. Soejima T, et al. 2007. Photoactivated ethidium monoazide directly cleaves bacterial DNA and is applied to PCR for discrimination of live and dead bacteria. Microbiol. Immunol. 51:763-775.
40. Song Y, Liu C, Finegold SM. 2004. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70:6459-6465.
41. Stackebrandt E, Kramer I, Swiderski J, Hippe H. 1999. Phylogenetic basis for a taxonomic dissection of the genus Clostridium. FEMS Immunol. Med. Microbiol. 24:253-258.
42. Su P, et al. 2005. Detection and quantification of Bifidobacterium lactis LAFTI B94 in human faecal samples from a consumption trial. FEMS Microbiol. Lett. 244:99-103.
43. Topping DL, Clifton PM. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81:1031-1064.